St. Jude Medical Announces One-Year Results From MASCOT Trial

St. Jude Medical, Inc. (NYSE:STJ) announced the one-year results from its 409-patient Management of Atrial Fibrillation Suppression in AF-HF Comorbidity Therapy (MASCOT) trial. The findings were presented during a late-breaking clinical trials session of the American Heart Association Scientific Sessions 2007 in Orlando, Fla. The MASCOT trial was designed to determine whether the St. [click link for full article]

More: continued here

Filed under: Cardiovascular on November 9th, 2007